Dr. Daniel Hartung discusses the association between Medicare Part D Plan disease-modifying therapy restrictiveness and adherence and outcomes among people with multiple sclerosis.
Show references:
https://cp.neurology.org/content/12/1/36
https://www.neurology.org/podcast
